FierceBiotech Feb 4, 2026 Lilly drops 3 pipeline drugs, including gene therapy, from $1B Prevail buyout
Thermo Fisher Feb 4, 2026 Is Thermo Fisher Scientific (TMO) Pricing Look Reasonable After Recent Share Price Weakness - simplywall.st
Endpoints News Feb 4, 2026 Rare pediatric PRV program reauthorized until 2029 via government funding law
BioPharma Dive Feb 4, 2026 Trump signs funding bill with PBM reforms, hospital-at-home and telehealth extensions
10x Genomics Blog Feb 4, 2026 PharosAI and 10x Genomics partner to transform cancer research with AI and spatial biology - marketscreener.com
BioPharma Dive Feb 4, 2026 Lilly soars again as fast-selling weight loss drugs top Wall Street projections
FierceBiotech Feb 4, 2026 Hims & Hers to sell Grail’s Galleri multi-cancer blood test via its digital health platform